Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Apple/ Eli Lilly’s bet: Wearable and mobile consumer devices may well help us detect cognitive impairment and dementia

__________

Apple, Eli Lil­ly research whether devices can detect demen­tia signs (Health­care Dive):

Demen­tia, which affects rough­ly 47 mil­lion peo­ple across the globe, costs $1 tril­lion world­wide, accord­ing to the World Health Orga­ni­za­tion. Ear­ly test­ing for the con­di­tion is spo­radic and, when con­duct­ed, it’s often not sen­si­tive enough to detect ear­ly stages of men­tal decline, cre­at­ing an oppor­tu­ni­ty for tech com­pa­nies like Apple to see whether they can turn a prof­it.

The “rich, lon­gi­tu­di­nal infor­ma­tion” from wear­able and mobile con­sumer devices can be Read the rest of this entry »

February 26–28th: Save the Date for the 2019 SharpBrains Virtual Summit and help shape the Future of Brain Health

Imag­ine a free annu­al brain check-up — who should take it, and how could it help prevent/ delay/ treat cog­ni­tive decline and Alzheimer’s Dis­ease?

Imag­ine your smart­phone can detect ear­ly signs of depres­sion or Parkinson’s Dis­ease — would you like to know? Who else should know … or not know?

Imag­ine a videogame cleared by the FDA to treat ADHD or sub­stance abuse — how will doc­tors pre­scribe it, patients access it, and insur­ers pay for it?

Imag­ine being respon­si­ble for the health & well­ness of 100,000 peo­ple — how will you help them nav­i­gate inter­ven­tions such as breathing/ exercise/ meditation/ apps/ biofeedback/ tDCS to reg­u­late stress?

Imag­ine invest­ing $100 mil­lion in star­tups devel­op­ing non­in­va­sive, dig­i­tal neu­rotech­nolo­gies — where, and how, will you find great oppor­tu­ni­ties to gen­er­ate finan­cial and social returns?


The 2019 Sharp­Brains Vir­tu­al Sum­mit (Feb­ru­ary 26–28th, 2019)  will fea­ture over forty of the world’s top experts, inno­va­tors and investors aim­ing to improve brain health and per­for­mance for all in light of grow­ing neu­ro­science and dig­i­tal tech.

Learn More and Reserve your Spot HERE

Learn More and Save the Date for the 2018 SharpBrains Virtual Summit (December 4–6th)

Imag­ine a videogame cleared by the FDA to treat ADHD, depres­sion, or sub­stance abuse — how will doc­tors pre­scribe it, patients access it, and insur­ers pay for it?

Imag­ine a free “annu­al brain check-up” — what may it look like, and how can it lead into per­son­al­ized inter­ven­tions to improve func­tion and prevent/ delay/ treat cog­ni­tive decline and Alzheimer’s Dis­ease?

Imag­ine being respon­si­ble for the health & well­ness of a mil­lion peo­ple — how will you edu­cate them to nav­i­gate most-like­ly-to-help inter­ven­tions, such as breathing/ exercise/ meditation/ apps/ biofeedback/ tDCS to reg­u­late stress?

Imag­ine invest­ing $100 mil­lion in star­tups devel­op­ing non­in­va­sive, dig­i­tal neu­rotech­nolo­gies — where, and how, will you find great oppor­tu­ni­ties to gen­er­ate finan­cial and social returns?


The 2018 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 4–6th, 2018)  will fea­ture over forty of the world’s top experts, inno­va­tors and investors aim­ing to improve brain health and per­for­mance for all in light of grow­ing neu­ro­science and dig­i­tal tech.

Learn More and Reserve your Spot HERE

Update: Why monitoring Typing Cadence may help detect early Parkinson’s and Alzheimer’s Disease

Above: Pat­tern of Typ­ing Cadence in 52-year-old male with Parkin­son’s. Source: Neu­raMetrix

_____

Time for Sharp­Brains’ first eNewslet­ter in 2018, offer­ing a fas­ci­nat­ing sneek peek into the rapid­ly grow­ing toolk­it to mea­sure and improve brain health.

(And don’t miss the fun teas­er at the end!)

New thinking:

New research:

New tools:

 

 

Final­ly, a quick brain teas­er. What do you see first, ani­mals or peo­ple?

 

Have a great month of Feb­ru­ary!

Study: 46.7 million Americans have Alzheimer’s Disease brain pathology today, so it’s urgent to prevent or at least delay progression to clinical disease

– In the Alzheimer’s affect­ed brain, abnor­mal lev­els of the beta-amy­loid pro­tein clump togeth­er to form plaques (seen in brown) that col­lect between neu­rons and dis­rupt cell func­tion. Abnor­mal col­lec­tions of the tau pro­tein accu­mu­late and form tan­gles (seen in blue) with­in neu­rons, harm­ing synap­tic com­mu­ni­ca­tion between nerve cells. Source: NIA

New fore­cast shows 6 mil­lion with Alzheimer’s dis­ease, cog­ni­tive impair­ment; The num­bers will more than dou­ble to 15 mil­lion by 2060 (NIH news):

Using new method­ol­o­gy, sci­en­tists cal­cu­late that approx­i­mate­ly 6 mil­lion Amer­i­can adults have Alzheimer’s dis­ease or mild cog­ni­tive impair­ment, which can some­times be a pre­cur­sor to the dis­ease. The esti­mate, fund­ed by the Nation­al Insti­tutes of Health, also fore­casts that these num­bers will more than dou­ble to 15 mil­lion by 2060, as the pop­u­la­tion ages Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.